Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto - 6-MTH group results

Nov 11 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               91.02               83.00           190.00    
                                       (-8.2 pct)       (+4.8 pct)  
  Operating           13.77               10.17            25.00    
                                       (-2.1 pct)       (+8.7 pct)  
  Recurring           13.51               10.48            25.00    
                                       (-3.7 pct)       (+4.6 pct)  
  Net                 10.76                5.80            18.00    
                                       (-20.6 pct)      (+7.5 pct)  
  EPS               94.30 yen           50.83 yen       157.80 yen  
  EPS Diluted       94.03 yen           50.68 yen                   
  Ann Div                               28.00 yen        30.00 yen  
  -Q2 div           15.00 yen           13.00 yen                   
  -Q4 div                               15.00 yen        15.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news